Einstein-Mount Sinai Diabetes Research Center

爱因斯坦西奈山糖尿病研究中心

• 批准号: 8872956
• 负责人: STREAMSON C CHUA
• 金额: $ 13.92万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-05-10 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8872956
• 关键词: Advertising; Area; Award; Budgets; Clinical; Clinical Sciences; Collaborations; Communities; Complications of Diabetes Mellitus; Core Facility; Data; Diabetes Mellitus; Discipline; Eligibility Determination; Ensure; Extramural Activities; Faculty; Feasibility Studies; Fostering; Funding; Funding Agency; Future; Generations; Goals; Grant; Individual; Institutes; Laboratories; Mentors; Metabolic Diseases; Metabolism; Mission; Modality; Modeling; Monitor; Obesity; Patient Care; Pilot Projects; Publications; Recording of previous events; Request for Applications; Research; Research Personnel; Scientist; Seeds; Services; Textiles; Translational Research; United States National Institutes of Health; base; cost effective; design; experience; improved; interest; member; novel; novel strategies; programs; success

The mission of the Pilot & Feasibility Study (P&F) Program is to provide initial support for new investigators, for established investigators to explore new directions, and to enable the Einstein-Mount Sinai Diabetes Research Center (ES-DRC) to attract scientists from other disciplines to diabetes research. The P&F Program is a vital component of the ES-DRC and has successfully promoted numerous new research endeavors in diabetes- related areas. This program constitutes a key interface among the Einstein, Mount Sinai and other regional academic communities at large, and serves as a major attraction in the recruitment of faculty and staff. Over the past 37 years the Center funded 113 feasibility studies from a pool of 449 applications (funding rate of 25.1%). These studies also include targeted efforts in this project period to increase the number of applications funded in our regional center at both the basic, clinical and translational diabetes efforts. We anticipate funding 7 Pilot & Feasibility grants at steady state, alternating between 4 new awards and 3 continuing awards, each year; typically, projects are funded for two years if sufficient progress is shown after the first year. The P&F study program has enabled recipients to obtain data and publications that constituted the basis for successful applications for extramural support. Under the same administrative umbrella as the Pilot & Feasibility program, we established a microgrant award program that provides specific support for the use of ES-DRC Core facilities. Last year, the microgrant program funded 8 awards out of 19 submitted applications. In addition, we also partner with the Einstein Clinical and Translational Science Award on a catalytic seed grant to support diabetes-specific translation research. These value added programs further enhance diabetes directed research efforts. To continue these established and new initiatives within the P&F program, we will: 1) advertise and organize the yearly P&F grant competition cycle; 2) support mechanisms for interaction and collaboration among established researchers in diabetes and related areas and for those who are new to the field; 3) provide mentoring and guidance for investigators who are new to diabetes research to facilitate generation of preliminary data with the goal of successful applications for NIH funding and other funding sources; 4) communicate responsibilities and opportunities to P&F awardees by integrating them into ES-DRC activities; 5) provide $10,000 of free use of each ES-DRC Biomedical Core services directly related to the funded P&F project; and 6) manage the institutionally microgrant and Catalytic Seed Grant Award programs in diabetes and metabolism.

飞行员与可行性研究（P＆F）计划的使命是为新调查人员提供初步支持， 建立的研究人员探索新的方向，并使爱因斯坦 - 马特·西奈糖尿病研究 中心（ES-DRC）吸引从其他学科到糖尿病研究的科学家。 P＆F计划至关重要 ES-DRC的组成部分，并成功促进了糖尿病的许多新研究努力 相关区域。该程序构成了爱因斯坦，西奈山和其他地区的关键界面 整个学术社区，并在招募教职员工方面是一个主要吸引力。超过 在过去的37年中，该中心资助了449个申请池的113项可行性研究 25.1％）。这些研究还包括在此项目期间增加申请数量的目标努力 在我们的区域中心资助的基本，临床和转化糖尿病工作。我们预计会有资金 7个飞行员和可行性赠款处于稳定状态，在4个新奖项和3个持续奖项之间交替 年;通常，如果在第一年之后显示出足够的进展，则将资助项目两年。 P＆F 研究计划使收件人获得了构成成功基础的数据和出版物 施用壁外支持。在与飞行员和可行性计划相同的行政伞下， 我们建立了一个微电奖计划，该计划为使用ES-DRC核心提供了特定的支持 设施。去年，微电磁计划资助了19项提交申请中的8个奖项。另外，我们 还与爱因斯坦临床和转化科学奖合作，获得催化种子赠款的支持 糖尿病特异性翻译研究。这些增值计划进一步增强了指导的糖尿病 研究工作。为了在P＆F计划中继续这些已建立的新计划，我们将：1） 宣传和组织年度P＆F赠款竞赛周期； 2）互动的支持机制 糖尿病和相关领域的知名研究人员以及为新手的研究人员之间的合作 场地; 3）为糖尿病研究新手的调查人员提供指导和指导，以促进 生成初步数据，目的是成功申请NIH资金和其他资金 来源； 4）通过将其纳入ES-DRC来传达给P＆F获奖者的职责和机会 活动; 5）提供$ 10,000的每种ES-DRC生物医学核心服务的$ 10,000 资助的P＆F项目； 6）管理机构微生物和催化种子赠款奖励计划 糖尿病和代谢。